Brief: Finch Therapeutics Group Inc Reports Quarterly Loss Per Share Of $0.56
23/03/2023 21:44
March 23 (Reuters) - Finch Therapeutics Group Inc
FNCH.O :
* FINCH THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
* FINCH THERAPEUTICS GROUP INC - QTRLY LOSS PER SHARE $0.56
* FINCH THERAPEUTICS GROUP INC - CASH AND CASH EQUIVALENTS
AS OF
DECEMBER 31, 2022 WAS $71.0 MILLION
* FINCH THERAPEUTICS GROUP - EXPECTS CASH & CASH EQUIVALENTS
AS OF
DEC 31,2022 TO FUND ITS OPERATING EXPENSES & CAPITAL
EXPENDITURES INTO 2025
Source text for Eikon: ID:nGNX7ClW1r
Further company coverage: FNCH.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Finch Therapeutics
See all newsFinch wins US jury trial against Ferring over fecal-transplant patents
Brief: Finch Therapeutics Group Received A Notice From Nasdaq Acknowledging Fact That Co Does Not Meet Requirements Of Rules On April 2
Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp